期刊文献+

脂质蓄积指数较腰围更好反映多囊卵巢综合征患者的胰岛素抵抗 被引量:2

Lipid Accumulation Product is Better than Waist Circumference in Identifying Insulin Resistance in Wowen with Polycystic Ovary Syndrome
原文传递
导出
摘要 目的:比较多囊卵巢综合征(PCOS)人群脂质蓄积指数(LAP)和腰围(WC)与胰岛素抵抗(IR)的相关性。方法:纳入121例PCOS患者和115例正常对照,测量人体参数及血液代谢指标,行75 g口服葡萄糖耐量试验,对其中20例对照及90例PCOS患者行高胰岛素-正葡萄糖钳夹术,并计算HOMA2-IR及LAP。结果:PCOS组LAP、WC等较对照组明显增高(P<0.05),胰岛素敏感性明显降低(P<0.05);匹配WC和年龄后,PCOS组LAP仍明显高于对照组(P<0.01),胰岛素敏感性明显低于对照组(P<0.05);与WC相比,LAP与M值(r=-0.66 vs r=-0.68,P<0.01)及HOMA2-IR(r=0.49 vs r=0.55,P<0.01)间关系更密切,校正WC后,LAP仍与M值(r=-0.37,P<0.01)及HOMA2-IR(r=0.26,P<0.01)相关;二项Logistic回归显示,高LAP患者发生IR的风险是正常LAP患者的6.05倍(OR=6.05,95%CI:1.67,21.90,P<0.05)。结论:在PCOS人群中,LAP与胰岛素敏感性相关,较WC更好地反映IR。 Objective: To compare association of lipid accumulation product(LAP) and waist circumference(WC) with insulin resistance(IR) in women with polycystic ovary syndrome(PCOS).Methods: A total of 121 PCOS patients and 115 age-matched controls were enrolled.Anthropometric index and fasting serum metabolic parameters were determined.An oral glucose tolerance test with 75 g glucose was performed on all subjects.Ninty PCOS subjects and 20 controls underwent euglycaemic-hyperinsulinaemic clamp to assess their insulin sensitivity,which was expressed as M value.The HOMA2-IR and LAP[(WC-58)×TG] were then calculated.Results: Compared with control subjects,PCOS women had significantly higher LAP and WC levels and decreased insulin sensitivity(P0.05).Subgroup analysis showed that compared with age-and WC-matched controls,PCOS women still had decreased insulin sensitivity and increased LAP levels(P0.05).Both LAP and WC were correlated with M value(r=-0.68 vs r=-0.66,P0.01) and HOMA2-IR(r=0.55 vs r=0.49,P0.01),and after adjusted for WC LAP still correlated with M value(r=-0.37,P0.01) and HOMA2-IR(r=0.26,P 0.01).Binary Logistic regression analysis revealed that the risk of IR in high LAP group was 6.05 times of that in the normal LAP group(OR=6.05,95%CI: 1.67,21.90,P0.05).Conclusion: In women with PCOS,LAP is associated with insulin sensitivity and it has a better correlation with IR than WC.
出处 《生殖与避孕》 CAS CSCD 北大核心 2011年第12期811-816,共6页 Reproduction and Contraception
基金 重庆市科委自然科学基金资助项目 项目号:CSTC2008BB5206
关键词 多囊卵巢综合征(PCOS) 胰岛素抵抗(IR) 脂质蓄积指数(LAP) 腰围(WC) polycystic ovary syndrome(PCOS) insulin resistance(IR) lipid accumulation product(LAP) waist circumference(WC)
  • 相关文献

参考文献4

二级参考文献24

  • 1胡晓抒,郭志荣,周慧,史祖民,武鸣,张均,孙国祥,周正元,潘晓群,姚才良.江苏省35~74岁人群代谢综合征的流行病学调查[J].中华流行病学杂志,2006,27(9):751-756. 被引量:110
  • 2Ford ES,Williamson DF,Liu S.Weight change and diabetes incidence:findings from a national cohort of US adults.Am J Epidemiol,1997,146:214-222.
  • 3Wannamethee SG,Shaper AG,Walker M.Overweight and obesity andweight change in middle aged men:impact on cardiovascular disease and diabetes.J Epidemiol Community Health,2005,59:134-139.
  • 4Frayn KN,Karpe F,Fielding BA,et al.Integrative physiology of human adipose tissue.Int J Obes Relat Metab Disord,2003,27:875-888.
  • 5Karelis AD,St Pierre DH,Conus F,et al.Metabolic and body composition factors in subgroups of obesity:what do we know?J Clin Endoerinol Metab,2004,89:2569-2575.
  • 6Lewis GF,Carpentier A,Adeli K,et al.Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.Endocr Rev,2002,23:201-229.
  • 7Schaffer JE.Lipotoxicity:when tissues Overeat.Curt opin Lipidol,2003,14:281-287.
  • 8Unger RH.Weapons of lean body mass destruction:the role of ectopic lipids in the metabolic syndrome.Endocrinology,2003,144:5159-5165.
  • 9Kahn HS.Thelipid accumulation product is better than BMI for identifying diabetes.Apopulation-basedcomparison.Diabetes Care,2006,29:151-153.
  • 10Kahn HS.The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk:a population-based comparison.BMC Cardiovasc Disord,2005,5:26.

共引文献1802

同被引文献24

  • 1邢小燕,杨文英,杨兆军.胰岛素抵抗指数在不同糖耐量人群中诊断代谢综合征的作用[J].中国糖尿病杂志,2004,12(3):182-186. 被引量:124
  • 2YU L, ZHANG Y H, LIU Y Y, et al. Comparison of three diagnosis criteria for metabolic syndrome in mongo- lian people of agricultural and pastoral regions [J]. J Endocrinol Invest, 2009, 32 (5): 420-425.
  • 3LORENZO C, WILLIAMS K, HUNT K J, et al. The national cholesterol education program-aduh treatment panel Ⅲ, international diabetes federation, and World Health Organization definitions of the metabolic syn- drome as predictors of incident cardiovascular disease and diabetes [ J]. Diabetes Care, 2007, 30 ( 1 ) : 8- 13.
  • 4SAITO I. Epidemiological evidence of type 2 diabetes mellitus, metabolic syndrome, and cardiovascular dis- ease in Japan [J]. Circ J, 2012, 76 (5): 1066- 1073.
  • 5KAHN H S. The "lipid accumulation product" performs better than the body mass index for recognizing cardio- vascular risk: a population-based comparison [ J]. BMC Cardiovasc Disord, 2005, 8 (5) : 26.
  • 6KAHN H S. The lipid accumulation product is better than BMI for identifying diabetes [ J ]. Diabetes Care, 2006. 29 (1) : 151-153.
  • 7中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中华糖尿病杂志,2010,2(增刊2):42-43.
  • 8DESPRE'S J P, LEMIEUX I, BERGERON J, et al. Abdominal obesity and the metabolic syndrome: contri- bution to global cardiometabolic risk [ J ]. Arterioscler Thromb Vasc Biol, 2008, 28 (6): 1039-1049.
  • 9WEHR E, GRUBER H J, GIULIANI A, et al. The lip- id accumulation product is associated with impaired glu- cose tolerance in PCOS women [ J ]. J Clin Endocrinol Metab, 2011,96 (6) : E986-990.
  • 10WILTGEN D, BENEDETI'O I G, MASTELLA L S, et al. Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome [ J ]. Hum Reprod, 2009, 24 (7) : 1726-1731.

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部